Target intelligence / Profile preview

Corneal epithelial surface and tear film

Molecular classification
Biological barrier, Physiological interface, Other
01

Overview

The corneal epithelial surface and the overlying tear film constitute a complex, integrated functional unit essential for maintaining ocular health and visual clarity (StatPearls, 2023). The tear film is a dynamic structure composed of an outer lipid layer, a middle aqueous layer, and an inner mucin layer that interacts with the corneal glycocalyx to provide a smooth refractive surface and lubricate the ocular surface (NIH, 2023). The corneal epithelium acts as a physical and immunological barrier, utilizing tight junctions to prevent the entry of pathogens and environmental toxins into the deeper corneal layers (PubMed, 2021). Dysfunction of this interface, often characterized by tear film instability or hyperosmolarity, is the hallmark of dry eye disease, leading to chronic inflammation and potential epithelial damage (TFOS DEWS II, 2017). Therapeutic strategies targeting this system include the use of lubricants to supplement tear volume, lipid-based emulsions to reduce evaporation, and anti-inflammatory agents like cyclosporine to address the underlying immune-mediated damage to the ocular surface (PubMed, 2022). Additionally, newer treatments like perfluorohexyloctane focus specifically on stabilizing the lipid layer to prevent excessive tear evaporation.

Other names
Ocular surfacePrecorneal tear filmCorneal-tear interfaceTear film-corneal epithelium unit
02

Mechanism of action

Lubrication, tear film stabilization, reduction of evaporation, osmoprotection, and inhibition of T-cell mediated inflammation.

03

Biological functions

Visual refractionOcular lubricationPhysical protectionAntimicrobial defenseHomeostasisImmune responseOther
04

Disease associations

Dry eye diseaseKeratoconjunctivitis siccaCorneal ulcerMeibomian gland dysfunctionKeratitisInflammationInfectionOther
05

Safety considerations

Ocular irritationBlurred visionPreservative-induced toxicity (e.g., benzalkonium chloride)Risk of secondary infection if barrier is compromised
06

Interacting drugs

Cyclosporine

5 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Tear osmolarityCorneal fluorescein stainingSchirmer test scoreMatrix metalloproteinase-9 (MMP-9) levels

Beyond the preview

Go deeper on Corneal epithelial surface and tear film.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal epithelial surface and tear film.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call